News Focus
News Focus
icon url

runncoach

09/30/21 7:48 AM

#2483 RE: Investor2014 #2482

Not IMO. I don't think a 500 patient trial is going to cut it when the fda wants SAVA to have 2 pivotal trials of much larger numbers and has approved the protocols. I think the odds of the current anavex trial that is a year to read out of being pivotal as under 10%